Online 2021 Annual Symposium Micro- and nanotechnologies for medicine and life sciences

The future of science in the 21st century

Due to the COVID-19 situation, it has been decided that the annual event would be online.

Our next symposium, on Micro and Nanotechnologies for Medicine and Life Sciences, will be held on April 14th, 2021.

Please register online on the following link:.

We are honoured to announce that Springer Nature, through Discover Materials journal, supports this event.

Note on their website


Opening speeches


Mr. Jean-Eric Paquet, European Commission, Director-General, DG Research and Innovation
Horizon Europe FP9


Pr. Elias Fattal, University Paris-Orsay, Pharmacy Faculty, Galien Institute
Nanomedicine for tackling physiological resistances to drug delivery


Pr. Stefaan de Smet, Ghent University, EURASC
Physico-Chemistry of nanoparticles for drug delivery


Dr. Carine Giovannangeli, CNRS – National Museum of Natural History
Genome modification and gene editing




Dr. Ana Buj-Bello, Généthon Laboratory, Inserm
Gene therapy of neuromuscular disorders with viral-derived vectors


Pr. Daniel Scherman, Foundation for Rare Diseases, Pharmacy Faculty, Paris University, CNRS, Inserm, EURASC
Genetic Pharmacology: RNA-silencing nanoparticles and targeted nanodrugs for rare diseases


Pr. Odile Launay, Haut Conseil de la Santé Publique, Professor of Infectiology Hôpital Cochin-Broca-Hôtel-Dieu
Strategies of COVID-19 vaccination


Pr. Neil Ferguson, Imperial College, London
Modelling of the Covid-19 pandemic. Connections with computational science, mathematical epidemiology, and control and vaccination policy making


Pr. Alain Fischer, Imagine Institute, Necker Hospital, French Academy of Sciences and Academy of Medicine
Gene therapy of severe immune rare diseases


Dr. Hervé Chneiweiss Inserm, Président od Inserm Ethics Committee and of CCNE (Comité Consultatif National d’Ethique pour les sciences de la vie et de la santé)
Ethical considerations in Biomedicine


Closure of the scientific day